LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged common law estoppel · clear

PTAB

Finality Aspect of Common Law Estoppel May Not Matter for PTAB Estoppel Under 315(e)

Standing Dispute Highlights 315(e)(2) Estoppel Concern Article III standing has been a problem for certain petitioners seeking review of adverse Patent Trial & Appeal Board (PTAB) AIA trial rulings. This is because, while the AIA statutes provide that…

May 15, 2019·PTAB·2 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.